Male breast carcinoma
MONDO:0005628A malignant neoplasm involving the male breast.
Also known as: Male breast cancer, Male breast carcinoma, carcinoma of Male breast, carcinoma of male breast, carcinoma of the Male breast, male breast cancer, male breast carcinoma, breast cancer in men
2826 clinical trials for this condition and its sub-types, 22 tagged with Male breast carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New combo aims to stop early breast cancer in its tracks
Disease control Recruiting nowThis phase 3 trial is testing whether adding the targeted drug ribociclib to standard hormone therapy can help prevent invasive breast cancer from returning in people with HR+ HER2- early breast cancer. About 1,400 participants will receive the combination for up to 3 years. The …
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug aims to stop breast cancer from coming back in high-risk patients
Disease control Recruiting nowThis study tests a new drug called elacestrant against standard hormone therapy in people with a certain type of early breast cancer (ER+/HER2-) that has spread to lymph nodes and has a high chance of returning. About 4,220 participants will be randomly assigned to receive either…
Phase 3 • Sponsor: Stemline Therapeutics, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New study aims to find best Pre-Surgery hormone treatment for men with breast cancer
Disease control Recruiting nowThis study tests different hormone therapies in men with breast cancer before they have surgery. The goal is to see which treatment works best to shrink the tumor. About 60 men with hormone receptor-positive breast cancer will take part.
Phase 2 • Sponsor: Jose Pablo Leone • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Chatbot aims to close genetic testing gap for cancer patients
Knowledge-focused Recruiting nowThis study tests whether a computer-generated character (PERLA) can effectively educate cancer patients about genetic testing, compared to a human genetics counselor. Researchers will enroll 800 people with certain cancers, including breast, ovarian, pancreatic, and prostate canc…
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
2000 patients to fuel breast cancer discoveries
Knowledge-focused Recruiting nowThis study collects tumor samples and medical information from 2000 people with breast cancer that has spread or come back. The goal is to create a resource for researchers to learn more about how the disease progresses and responds to treatments. No new treatments are tested her…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC